Meet the Biogazelle team in Spring 2019
In the coming months, Biogazelle will be attending several conferences. Meet us at one of these events:
- March 18-22, qPCR, dPCR and NGS in Munich
- March 25-27, BIO-Europe Spring in Vienna
- March 25-26, Revolutionizing NGS in Antwerp
- April 11-12, 12th Clinical Trials Innovation Programme in Frankfurt
- April 15-18, World CB and CDx in London
- May 7, Swiss Biotech Day in Basel
- May 9, Knowledge for Growth in Ghent
- May 14-15, Outsourcing in Clinical Trials in Milan
- May 20-21, 4th Annual Advances in Immuno-Oncology Congress in London
- May 21-22, MEET2WIN Oncology Partnering Convention in Bordeaux
9th Gene Quantification Event qPCR dPCR & NGS 2019
March 18 to 22, Munich (Germany)
This bi-yearly event focuses on genomics applications from RT-qPCR to digital PCR and the latest NGS technologies and data analysis and molecular diagnostics.
As expert in PCR (both quantitative and digital) and RNA sequencing, Biogazelle always participates in this event.
Our CSO, prof. Jo Vandesompele will be chairing the Liquid Biopsy session on Tuesday 19th in the morning and give a presentation on “Exploiting RNA in liquid biopsies for precision medicine purposes”.
Our expert scientist prof. Pieter Mestdagh will be attending too, and presenting “HTPathwaySeq, a Novel Application for High-throughput RNA Sequencing Based Pathway Phenotyping” on Monday 18th, 11.30h.
Contact us if you like to set up a meeting with them in advance.
March 25 to 27, Vienna (Austria)
The Spring edition of Bio-Europe brings along about 2500 attendees from 55 countries, making of it one of the largest life sciences partnering conferences, with thousands of prescheduled one-to-one meetings.
Revolutionizing Next-Generation Sequencing
March 25 to 26, Antwerp, Belgium
During this 3rd edition VIB (Flanders Institute of Biotechnology) will bring together over 30 top scientists and technology developers from both industry and academia. They will discuss emerging tools and approaches in several sessions on the latest advances in next-generation sequencing.
Our CTO, dr. Jan Hellemans will attend the event and present our HTPathwaySeq solution in the poster session. Should you be willing to meet with him, please contact us.
12th Clinical Trials Innovation Programme
April 11th and 12th, Frankfurt (Germany)
This conference covers several topics around knowledge, innovation and technologies in the frame of clinical trials. With an emerging need for new biomarkers and genomic and transcriptomic testing in clinical trials, Biogazelle will be present at this event to present our capabilities and why we could be an excellent partner for you.
Our business development manager dr. Nathalie Bernard and business unit manager dr. Ariane De Ganck will attend this exciting event. Pass by our booth CTIPEU05 or contact them to set up a meeting in advance.
World CB and CDx Europe
April 15 to 17th, London (UK)
With growing implementation of clinically relevant, biomarker-based diagnostics, the development companion diagnostics and recent changes in IVD regulation in Europe, this conference brings together biomarker, translational, clinical and regulatory aspects to pave the way towards the adoption of diagnostic-enabled precision medicines.
Swiss Biotech Day
May 7th, Basel (Switzerland)
Biogazelle will be attending the annual get-together of the Swiss bio¬pharmaceutical industry, including the presentation of emerging companies, panel discussions and partnering meetings.
Contact us if you would like to set up a meeting upfront.
Knowledge for Growth
May 9th, Ghent (Belgium)
Biogazelle will be attending the 15th edition of flanders.bio’s annual knowledge for growth business conference, attracting decision makers from biotech, pharma and medtech, agricultural and chemical industry as well as investors, universities, topnotch research institutes, policymakers and competence providers.
9th annual Outsourcing in Clinical Trials Europe
May 14th and 15th, Milan (Italy)
The OTC conference is focused on providing solutions to operational and outsourcing challenges in clinical trials.
If you’re interested in learning more about Biogazelle’s capabilities as specialty lab for genomic and transcriptomic testing in clinical trials, pass by our booth (#52) to meet with our business development manager dr. Amparo Cuéllar and head of sales Alexander Baumann. If you would like to set up a meeting upfront, just contact us!
4th Annual Advances in Immuno-Oncology Congress
May 20th and 21st, London (UK)
This conference offers a comprehensive look at immuno-oncology drug development, translational science & pre/clinical development of key therapeutic strategies such as T-cell therapies, checkpoint inhibitors or oncolytic viral therapeutics, as well as towards biomarker-based, genomic and precision medicine strategies in the I/O field.
Do not miss the talk of Biogazelle's CSO prof. Jo Vandesompele on May 20th, stream 3 (Genomics in Cancer Immunotherapy, 14.40 – 15.10h), focused on “Exploiting tumor RNA sequencing data for prediction of immune checkpoint inhibition through TMB and MSI assessment”. Also, Jo will be chairing a session on May 21st, dedicated to discuss the value of RNA for prediction of response to immuno-oncology treatments.
For more information and to discuss potential projects were our expertise could be of value, please visit us on booth #23. Our CSO, prof. Jo Vandesompele and our head of sales Alexander Baumann are looking forward to meeting you!
MEET2WIN Oncology Partnering Convention
May 21st and 22nd, Bordeaux (France)
The 5th edition of its European Partnering Convention combines conferences addressing topical issues in oncology with networking and B2B meetings to increase collaboration opportunities.